Skip to main content
SpringerLink
Log in

Desmoidtumor

  • Chapter
Kompendium Internistische Onkologie

  • 98 Accesses

Zusammenfassung

Häufigkeit: Desmoide sind selten. Sie betreffen 0,03% aller Neoplasien.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  • Acker JC, Bossen EH, Halperin EC (1993) The management of desmoid tumours. Int J Radiat Oncol Phys 26:851–858

    Article  CAS  Google Scholar 

  • Alman BA, Li C, Pajerski ME et al (1997) Increased β-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151:329–334

    PubMed  CAS  Google Scholar 

  • Baker LH, Wathen K, Chugh R et al. Activity of imatinib mesylate in desmoid tumors: Item analysis of Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial. ASCO Annual Meeting Abstr. 9013

    Google Scholar 

  • Belliveau P, Graham AM (1984) Mesenteric desmoid tumor in Gardner’s syndrom treated by sulindac. Dis Colon Rectum 27:53–54

    Article  PubMed  CAS  Google Scholar 

  • Bonnici AV, Birjandi F, Spencer JD et al (1992) Chromosomal abnormalities in Dupuytren’s contracture and carpal tunnel syndrome. J Hand Surg 17:349–355

    CAS  Google Scholar 

  • Bridge AJ, Sreekantaiah Ch, Mouron BS et al (1992) Clonal chromosome abnormalities in desmoid tumors–implications for histopathogenesis. Cancer 69:430–436

    Article  PubMed  CAS  Google Scholar 

  • Dangel A, Meloni AM, Lynch HT, Sandberg AA (1994) Deletion (5q) in a desmoid tumor of a patient with Gardner’s syndrome. Cancer Genet Cytogenet 78:94–98

    Article  PubMed  CAS  Google Scholar 

  • Delepine N, Delepine G, Desbois JC et al (1987) Response objective du fibrome desmoide à la chimiotherapie. Biomed Pharmacother 41:146–148

    PubMed  CAS  Google Scholar 

  • Dominguez-Malagon HR, Alfeiran-Ruiz A, Chavaria-Xicotencatl P et al (1992) Clinical and cellular effects of colchicine in fibromatosis. Cancer 69:2478–2483

    Article  PubMed  CAS  Google Scholar 

  • Fernberg JO, Brosjo O, Larsson O et al (1999) Interferon-induced remission in aggressive fibromatosis of the lower extremity. Acta Oncol 38:971–972

    Article  PubMed  CAS  Google Scholar 

  • Gansar GF, Krementz ET (1988) Desmoid tumors: experience with new modes of therapy. South Med J 81:794–796

    Article  PubMed  CAS  Google Scholar 

  • Geurs F, Kok TC (1993) Regression of a great abdominal desmoid tumor by interferon-α. J Clin Gastroenterol 16:264–265

    Article  PubMed  CAS  Google Scholar 

  • Giaccone G, Donadio M, Calciati A (1989) A Phase II study of Esorubicin in the treatment of patients with advanced sarcoma. Oncology 46:285–287

    Article  PubMed  CAS  Google Scholar 

  • Goepfert H, Cangir A, Ayala AG, Eftekari F (1982) Chemotherapy of locally aggressive head and neck tumors in pediatric age group. Am J Surg 144:437–444

    Article  PubMed  CAS  Google Scholar 

  • Greenberg HM, Goebel R, Weichselbaum RR et al (1981) Radiation therapy in the treatment of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 7:305–310

    PubMed  CAS  Google Scholar 

  • Heidemann J, Ogawa H, Otterson MF et al. (2004) Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum 47:118–122

    Article  PubMed  Google Scholar 

  • Heng Qi, Dal Cin P, Hernández JM et al (1996) Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet 92:147–149

    Article  Google Scholar 

  • Hoffmann W, Weidmann B, Schmidberger H et al (1993) Klinik und Therapie der aggressiven Fibromatose (Desmoide). Strahlenther Onkol 169:235–241

    PubMed  CAS  Google Scholar 

  • Hoos A, Lewis JJ, Antonescu CR et al (2001 Characterization of molecular abnormalities in human fibroblastic neoplasms. A model for genotype-phenotype association in soft tissue tumors. Cancer Res 61:3171–3175)

    PubMed  CAS  Google Scholar 

  • Hutchinson RJ, Norris DG, Schnaufer L (1979) Chemotherapy: a successful application in abdominal fibromatosis. Pediatrics 63:157–159

    PubMed  CAS  Google Scholar 

  • Janinis J, Patriki M, Vini L et al (2003) The pharmacological treatment of aggressive fibromatosis: a systemic review. Ann Oncol 14:181–190

    Article  PubMed  CAS  Google Scholar 

  • Jelinek JA, et al. (2001) The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiat Oncol Biol Phys 50:121–125

    PubMed  CAS  Google Scholar 

  • Karlsson L, Mandahl N, Heim S et al (1988) Complex chromosome rearrangements in a extraabdominal desmoid tumor. Cancer Genet Cytogenet 34:241–245

    Article  PubMed  CAS  Google Scholar 

  • Keus R, Bartelink H (1986) The role of radiotherapy in the treatment of desmoid tumors. Radiother Oncol 7:1–5

    Article  PubMed  CAS  Google Scholar 

  • Khorsand J, Karakousis CP (1985) Desmoid tumors and their management. Am J Surg 149:215–218

    Article  PubMed  CAS  Google Scholar 

  • Kiel K, Suit HD (1984) Radiation therapy in the treatment of aggressive fibromatosis (desmoid tumors) Cancer 54:2051–2055

    Article  PubMed  CAS  Google Scholar 

  • Kinzbrunner B, Ritter S, Domingo J, Rosenthal J (1983) Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 52:2201–2204

    Article  PubMed  CAS  Google Scholar 

  • Kitamura A, Kanagawa T, Yamada S, Kawai T (1991) Effective chemotherapy for abdominal desmoid tumor in a patient with Gardner’s syndrome. Report of a case. Dis Colon Rectum 34:822–826

    Article  PubMed  CAS  Google Scholar 

  • Klein WA, Miller HH, Anderson M et al (1987) The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer 60:2863–2868

    Article  PubMed  CAS  Google Scholar 

  • Lanari A (1983) Effect of progesterone on desmoid tumors (aggressive fibromatosis) N Engl J Med 309:1523

    PubMed  CAS  Google Scholar 

  • Leibl SA, Wara WM, Hill DR et al (1983) Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys 9:1167–1171

    Google Scholar 

  • Leitner A, Schnack B, Katterschafka T et al (2000) Treatment of extraabdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol 73:21–25

    Article  Google Scholar 

  • Lev-Chelouche D, Abu-Abeid, Nakache R et al (1999) Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor alpha and melphalan. Surgery 126:963–967

    Article  PubMed  CAS  Google Scholar 

  • Li C, Bapat B, Alman BA (1998) Adenomatous polyposis coli gene mutation alters proliferation through its β catenin-regulatory function in aggressive fibromatosis (desmoid tumor) Am J Pathol. 153:709–714

    PubMed  CAS  Google Scholar 

  • Lucas DR, Shroyer KR, McCarthy PJ et al (1997) Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosom inactivation. Am J Surg Pathol 21:306–311

    Article  PubMed  CAS  Google Scholar 

  • Mace J, Sybil Biermann J, Sondak V et al. (2002) Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 95:2373–2379

    Article  PubMed  CAS  Google Scholar 

  • Mills B, Frausto A, Brien E (2000) Cytokines associated with the pathophysiology of aggressive fibromatosis. J Orthop Res 18:655–662

    Article  PubMed  CAS  Google Scholar 

  • Miralbell R, Suit HD, Mankin HJ et al (1990) Fibromatoses: From postsurgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys 18:535–540

    PubMed  CAS  Google Scholar 

  • Miyaki M, Konishi M, Kikuchi et al. (1993) Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 53:5079–5082

    PubMed  CAS  Google Scholar 

  • Nuyttens JJ, Rust Ph F, Thomas Ch R, Turrisi AT (2000) Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. Cancer 88:1517–1523

    Article  PubMed  CAS  Google Scholar 

  • Okuno SH, Edmonson JH (1999) Combination chemotherapy for desmoid tumors. Proceedings Fifth Annual Meeting Connective Tissue Oncology Society, Arlington, VA 32

    Google Scholar 

  • Pape H, Boeker H, Wurm R, Mills EED, Schmitt G (1993) Klinisches Verhalten und Therapie der Desmoide: Eigenbeobachtung an 26 Patienten und Literaturüberblick. Tumordiagn Ther 14:244–251

    Google Scholar 

  • Patel SR, Evans HL, Benjamin RS (1993) Combination chemotherapy in adult desmoid tumors. Cancer 72:3244–3247

    Article  PubMed  CAS  Google Scholar 

  • Pilz T, Pilgrim TB, Bisogno G et al (1999) Chemotherapy in fibromatoses of childhood and adolescence: results from Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP). Klin Pädiatr 211:291–295

    Article  PubMed  CAS  Google Scholar 

  • Poon R, Smits R, Li C (2001) Cyclooxygenase–two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20:451–460

    Article  PubMed  CAS  Google Scholar 

  • Posner MC, Shiu MH, Newsome JL et al (1989) The desmoid tumor. Not a benign disease. Arch Surg 124:191–196

    PubMed  CAS  Google Scholar 

  • Reich S, Overberg-Schmidt US, Buhrer C, et al (1999) Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. J Clin Oncol 17:1086

    PubMed  CAS  Google Scholar 

  • Samuels BL, Barbour L, Tolzien K, Hajba A (2002) High-dose toremofine (T) in the treatment of desmoid tumors (DT), ASCO Annual Meeting Abstr. 1642

    Google Scholar 

  • Schmidt D, Klinge P, Leuschner I, Harms D (1991) Infantile desmoid-type fibromatosis. Morphological features correlate with biological behaviour. J Pathol 164:315–319

    Article  PubMed  CAS  Google Scholar 

  • Schmitt G, Mills EE, Levin V et al (1992) Radiotherapy of aggressive fibromatosis. Eur J Cancer 28:832–835

    Article  Google Scholar 

  • Schröder M, Queiβer W (1994) Management of desmoid tumours. Onkologie 17: 376–380

    Article  Google Scholar 

  • Seiter S, Kemeny N (1993) Successfull treatment of a desmoid tumor with doxorubicin. Cancer 71:2242–2244

    Article  PubMed  CAS  Google Scholar 

  • Sen-Gupta S, Van der Luijt RB, Bowles LV et al (1993) Somatic mutation of APC gene in desmoid tumour in familial adenomatous polyposis. Lancet 342:552–553

    Article  PubMed  CAS  Google Scholar 

  • Sergovich FR, Botz JS, MC Farlane RM (1983) Non random cytogenetic abnormalities in Dupuytren’s disease [Letter]. New Engl J Med 308:162–163

    PubMed  CAS  Google Scholar 

  • Shermann NE, Romsdahl M, Evans H et al (1990) Desmoid tumors: a 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys 19: 37–40

    Google Scholar 

  • Spear MA, Jennings LC, Mankin HJ et al (1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 403:637–645

    PubMed  CAS  Google Scholar 

  • Sportiello DJ, Hoogerland DL (1991) A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer 67:1443–1446

    Article  PubMed  CAS  Google Scholar 

  • Stein R (1977) Chemotherapeutic response in fibromatosis of the neck. J Pediatr 90:482–483

    Article  PubMed  CAS  Google Scholar 

  • Stockdale AD, Cassoni AM, Coe MA et al (1988) Radiotherapy and conservative surgery in the management of musculoaponeurotic fibromatosis. Int J Radiat Oncol Biol Phys 15: 851–857

    PubMed  CAS  Google Scholar 

  • Thomas S, Das Gupta S, Kapur BM (1990) Treatment of recurrent desmoid tumor with tamoxifen. Aust N Z J Surg 60:919–921

    Article  PubMed  CAS  Google Scholar 

  • Tsukada K, Church J, Jagelman G et al (1991) Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis. Dis Colon Rectum 34:1090–1092

    Article  PubMed  CAS  Google Scholar 

  • Tsukada K, Church JM, Jagelman DG et al (1992) Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 35:29–33

    Article  PubMed  CAS  Google Scholar 

  • Umemoto SH, Makuuchi H, Amemiya T et al (1991) Intra-abdominal desmoid tumors in familial polyposis coli: A case report of tumor regression by prednisolone therapy. Dis Colon Rectum 34:89–93

    Article  PubMed  CAS  Google Scholar 

  • Waddel WR, Gerner RE (1980) Indometacin and ascorbate inhibit desmoid tumors. Journal of Surgical Oncology 15:85–90

    Article  Google Scholar 

  • Waddel WR, Gerner RE, Reich MP (1983) Non steroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 22:197–211

    Article  Google Scholar 

  • Waddel WR, Kirsch WM (1991) Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 161:416–421

    Article  Google Scholar 

  • Weiss AJ, Lackmann RD (1989) Low dose chemotherapy of desmoid tumors. Cancer 64:1192–1194

    Article  PubMed  CAS  Google Scholar 

  • Wilcken N, Tattersal MH (1991) Endocrine therapy for desmoid tumors. Cancer 68:1384–1388

    Article  PubMed  CAS  Google Scholar 

  • Wildfang I, Gründel O, Schmoll H-J (1994) Intratumoral interferon treatment in combination with local radiotherapy in 5 patients with recurrent soft tissue sarcomas. J Cancer Res Clin Oncol 120(Suppl):R115, Abs. P2.14.03

    Google Scholar 

Download references

Authors
  1. H. Pape
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Wildfang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. -J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Schwerpunkt Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle/Saale

    Hans-Joachim Schmoll (Direktor der Klinik und Poliklinik für Innere Medizin IV) (Direktor der Klinik und Poliklinik für Innere Medizin IV)

  2. Onkologie-Hämatologie-Gastroenterologie-Hepatologie-Infektiologie, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, 07740, Jena

    Klaus Höffken (Direktor der Klinik und Poliklinik für Innere Medizin II) (Direktor der Klinik und Poliklinik für Innere Medizin II)

  3. Schwerpunkt Onkologie und Hämatologie, Universitätsmedizin Berlin, Charité-Campus Mitte Schumannstraße 20/21, 10117, Berlin

    Kurt Possinger (Direktor der Medizinischen Klinik II) (Direktor der Medizinischen Klinik II)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Pape, H., Wildfang, I., Schmoll, H.J. (2006). Desmoidtumor. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31303-6_261

Download citation

  • DOI: https://doi.org/10.1007/3-540-31303-6_261

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20657-6

  • Online ISBN: 978-3-540-31303-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation